Navigation Links
Tengion Provides Business Update and Reports Third Quarter 2011 Financial Results
Date:11/14/2011

tilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications.  An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal.  The Company's lead preclinical candidate is the Neo-Kidney Augment, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure.  Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment for the treatment of neurogenic bladder.  Tengion has worldwide rights to its product candidates.

Forward-Looking Statements Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to the Company's: (i) search for a new chief executive officer; (ii) expectations regarding the initial clinical trial of the Neo-Urinary Conduit and (iii) expectations regarding planned preclinical studies of the Neo-Kidney Augment. Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company will be able to find a suitable candidate for the position of chief executive officer or that the Company will be able to retain such person on mutually agreeable terms; (ii) the Company will be able to successfully enroll patients in its clinical trials, including its initial clinical trial for the Neo-Urinary Conduit; (iii)  the Company's Neo-Urinary Conduit clinical trial will not be
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Tengion Appoints Scott Flora to Board of Directors
2. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
3. Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
4. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
5. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
6. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
7. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
10. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
11. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... , July 4, 2015 ... for patients with unresectable metastatic colorectal cancer in ... that organ Patients with unresectable metastatic ... the liver experienced the greatest improvement in Progression-Free ... of SIR-Spheres Y-90 resin microspheres to a current ...
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
(Date:7/2/2015)... 3 juillet 2015 BGI a annoncé aujourd,hui ... de l,ADN situé à Hong Kong ... College of Pathologists  (Collège des pathologistes américains, ou ... Hong Kong constituent le premier laboratoire ... la certification du CAP en Chine, car il ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new ... a buzz of media attention. In an effort to spread the news, a ... , "These days many people are feeling overwhelmed by stress and fatigue," reports ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... MO (PRWEB) , ... July 03, 2015 , ... Talcum ... website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a ... features the latest and coolest technology products available to consumers. Amanda Forstrom, a technology ... these selfie sticks are great for documenting memories. , Almost every smartphone has an ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... ... the American Heart Association,s PTES campaign to raise funds and awareness for stroke prevention. We ... risk of stroke. Doctors Community Hospital will be onsite at the walk-a-thon providing free health ... Bowie, MD (PRWEB) ...
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... ... course this past March, and are on their way to becoming the first iPad developers ... ... ), the leader in online and OnDemand iPhone and iPad programming and marketing training, has ...
... Amphora Research Systems ... the revolutionary Apple iPad. , ... (PRWEB) April 5, 2010 -- Amphora Research Systems is delighted to announce the ... ,"Science often happens in places where using a Desktop PC or Laptop is inconvenient, but ...
... MONDAY, April 5 (HealthDay News) -- Researchers report that they,ve ... a finding that offers a possible new avenue toward a ... moment, there,s no way to know whether the research will ... enemy. , Still, the findings do give scientists an idea ...
... ... eco-friendly and affordable Robby Wash high efficiency laundry detergent balls. One Robby Wash hypoallergenic laundry ... saves more than $100 annually. The Robby Wash has been used for years in Europe ... ...
Cached Medicine News:Health News:Bowie/Mitchellville (MD) Alumni Chapter of Kappa Alpha Psi Hosts "Power to End Stroke" Walk-a-thon in Glenn Dale, Maryland 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:First iPad App Developers Graduate from Around the Globe: Ready to Show Their New Apps 2Health News:Amphora's PatentSafe Electronic Laboratory Notebook Fully Supported on the Apple iPad 2Health News:Scientists Find Clues to How the Body Fights Off HIV 2Health News:Robby Wash High Efficiency Laundry Detergent Offers 25% off Coupon – Replaces 75 lbs. of Traditional Laundry Detergent Saving $100 Annually 2Health News:Robby Wash High Efficiency Laundry Detergent Offers 25% off Coupon – Replaces 75 lbs. of Traditional Laundry Detergent Saving $100 Annually 3
... The eNclose Anastomosis ... specifically to obviate the ... of the aorta. The ... the surgeon with a ...
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, Thumb Screw Control; in Titanium....
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
Medicine Products: